Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Reality vs games
View:
Post by mercedesman on Sep 11, 2023 8:19am

Reality vs games

...2 months ago the # sites increased by 20%  ( 3/15 sites)

Will the potential enrollment rate have increased again (3 more) by the end of this month? 

Fewer FUD dummies are now predicting it will take 2, 3, 4+ years to get to 90 and 7 years to achieve 150? 

They are now down to 2 years on the 150.  That in itself is a major negative stretch - given: (1) more sites, (2) better sites - ie. newer ones enrolling at a faster pace, and (3) the shot in the arm  momentum increase from the famous May meeting, etc.)

Now add in the TV spot ( starting this Monday)

The FUD workers are down to extrapolating the month of August's enrolment (the slowest month typically becasue of ICU staff vacationing)

Possible Pathway to 90 BEFORE YEAR END from an earlier prediction by MM: 

july +3. cumm. 68     Cumulative Achieved 
aug +4. cumm 72      Cumulative achieved 
sept +5 cumm 77       TBD
oct +5  cumm. 82        TBD
nov + 6 cumm 88         TBD

I'm looking forward to a possible increase in the pace starting in Sept (post vacation period, new sites, etc.)

Personally, at 90, I am hoping for the release of some raw mortality stats at that time (interim data release) that might enable investors ( but at the very least Baxter) to statistically gauge the odds of ultimate FDA approval in this OPEN LABEL, BAYESIAN, CONFIRMATORY, 3B RCT TRIAL with a 28 DAY MORTALITY PRIMARY END POINT, clearing the pathway to a minimum of a $2BILLION USD market ( more likely $3-$5 B IMO) 

MM

Comment by oilandgasman on Sep 11, 2023 9:56am
Math don't lie..5 yars to get to 72... Calling poeple "dumb" isn't a good, belittleing others most likely won't help this math problem. No go frack yourself.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities